FBLG
Price:
$0.931
Market Cap:
$1.95M
FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline includes CybroCell, currently being developed to address degenerative disc disease; CYMS101, targeting multiple sclerosis; and CYWC628 for wound repair. Further demonstrating its broad scope, early-stage investigations are underway for CYTER915, aimed at restoring or enhancing thymus and/or spleen function; CYPS317, for psoriasis; and TCB190, designed to combat specific cancers. FibroBiologics was founded in 2021 and is situated in Houston, Texas.
Industry
Biotechnology
IPO Date
2024-02-01
Stock Exchange
NASDAQ
Ticker
FBLG
According to FibroBiologics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 1.59. This represents a change of -8.00% compared to the average of 1.73 of the last 4 quarters.
The mean historical Current Ratio of FibroBiologics, Inc. Common Stock over the last ten years is 1.06. The current 1.59 Current Ratio has changed 14.86% with respect to the historical average. Over the past ten years (40 quarters), FBLG's Current Ratio was at its highest in in the June 2023 quarter at 12.48. The Current Ratio was at its lowest in in the March 2022 quarter at 0.
Average
1.06
Median
0.69
Minimum
0
Maximum
3.61
Discovering the peaks and valleys of FibroBiologics, Inc. Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 3.61
Minimum Annual Increase = 0%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 3.61 | 222.84% |
| 2024 | 1.12 | 11.41% |
| 2023 | 1.00 | 170.39% |
| 2022 | 0.37 | 39.41% |
| 2021 | 0.27 | Infinity% |
The current Current Ratio of FibroBiologics, Inc. Common Stock (FBLG) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.91
5-year avg
1.27
10-year avg
1.06
FibroBiologics, Inc. Common Stock’s Current Ratio is greater than Daré Bioscience, Inc. (1.03), less than Athira Pharma, Inc. (10.38), greater than Aditxt, Inc. (0.06), greater than Ainos, Inc. (0.55), greater than Citius Pharmaceuticals, Inc. (0.58), greater than Moleculin Biotech, Inc. (1.38), less than Leap Therapeutics, Inc. (27.28), greater than Apollomics, Inc. (0.96), less than SeaStar Medical Holding Corporation (2.73), less than Hoth Therapeutics, Inc. (3.39),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.03 | $19.23M | |
| 10.38 | $26.62M | |
| 0.06 | $425.00 | |
| 0.55 | $8.65M | |
| 0.58 | $6.03M | |
| 1.38 | $14.09M | |
| 27.28 | $31.86M | |
| 0.96 | $15.78M | |
| 2.73 | $8.46M | |
| 3.39 | $14.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like FibroBiologics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like FibroBiologics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is FibroBiologics, Inc. Common Stock's Current Ratio?
How is the Current Ratio calculated for FibroBiologics, Inc. Common Stock (FBLG)?
What is the highest Current Ratio for FibroBiologics, Inc. Common Stock (FBLG)?
What is the 3-year average Current Ratio for FibroBiologics, Inc. Common Stock (FBLG)?
What is the 5-year average Current Ratio for FibroBiologics, Inc. Common Stock (FBLG)?
How does the current Current Ratio for FibroBiologics, Inc. Common Stock (FBLG) compare to its historical average?